References

  1. Data on file, Johnson & Johnson Consumer Inc. Based on overall mean percentage of healthy sites per subject after 6 months. Post hoc analysis of Sharma et al clinical study. Sharma N, Charles CH, Lynch M, et al. Adjunctive benefit of an essential oil-containing mouthrinse in reducing plaque and gingivitis in patients who brush and floss regularly: a six month study. Am J Dent Assoc. 2004;135(4):496-504.
  2. Sharma N, Charles CH, Lynch MC, et al. Adjunctive benefit of an essential oil-containing mouthrinse in reducing plaque and gingivitis in patients who brush and floss regularly: a six-month study. J Am Dent Assoc. 2004;135:496-504.
  3. CDA Seal Program Recognized Products: http://www.cda-adc.ca/en/oral_health/seal/products/.
  4. DePaola LG, Overholser CD, Meiller TF, Minah GE, Niehaus C. Chemotherapeutic inhibition of supragingival dental plaque and gingivitis development. J Clin Periodontol. 1989;16:311-315.
  5. Health Canada Product License for LISTERINE SMART RINSE® for KIDS
  6. Morris A, Santos S, Sinatra K, et al.  Plaque removal of revolutionary monofilament floss with Flexible MICRO-GROOVES®.  J Dent Res 2009;88(Spec Issue A): Abstract 1574.
  7. Asadoorian J. Canadian Dental Hygienists Association Position Statement on Oral Rinsing. CJDH 2006;40(4):1-13
  8. Ipsos Mouthwash Omnibus Study. December 20, 2001.
  9. Health Canada. Canadian Health Measures Survey 2007-2009, Table 15, Page 83.
  10. DePaola LG, Spolarich AE. Safety and efficacy of antimicrobial mouthrinses in clinical practice. J Dent Hygiene. 2007;81(special suppl):13-25.
  11. Fine DH, Furgang D, Lieb R, Korik I, Vincent JW, Barnett ML. Effects of sublethal exposure to an antiseptic mouthrinse representative plaque bacteria. J Clin Periodontol. 1996;23(5):444-451.
  12. Ricci-Nittel D, Fourre T. In vivo evaluation of antimicrobial activity of an essential-oil mouthrinse. Presented at: General Session of the International Association for Dental Research; March 16-19, 2011; San Diego, CA. Oral Session.
  13. Pan PC, Harper S, Ricci-Nittel D, Lux R, Shi W. In-vitro evidence for efficacy of antimicrobial mouthrinses. J Dent. 2010;38(suppl 1):S16-20.
  14. Fine DH, Letizia J, Mandel ID. The effect of rinsing with Listerine antiseptic on the properties of developing dental plaque. J Clin Periodontol. 1985;12:660-666.
  15. Ross NM, Charles CH, Dills SS. Long-term effects of Listerine antiseptic on dental plaque and gingivitis. J Clin Dent.  1989;1(4):92-95.
  16. Drake D, Villhauer AL. An in vitro comparative study determining bactericidal activity of stabilized chlorine dioxide and other oral rinses. J Clin Dent.  2011;22(1):1-5.
  17. Andreana S, Nittel-Ricci D, Wu MM, Harper DS, Baxter KA. 2205 In vitro antimicrobial activity of vanilla mint Listerine® antiseptic mouthrinse. Presented at: IADR/AADR/CADR 85th General Session and Exhibition. March 2007.
  18. Pan PH, Finnegan MB, Sturdivant L, Barnett ML. Comparative antimicrobial activity of an essential oil and an amine fluoride/stannous fluoride mouthrinse in vitro. J Clin Periodontol. 1999;26(7):474-476.
  19. Fine DH, Furgang D, Barnett ML, et al. Effect of an essential oil-containing antiseptic mouthrinse on plaque and salivary Streptococcus mutans levels. J Clin Periodontol. 2000;27(3):157-161.
  20. Fine DH, Letizia J, Mandel ID. The effect of rinsing with Listerine antiseptic on the properties of developing dental plaque. J Clin Periodontol. 1985;12:660-666.
  21. DePaola LG. Safety and efficacy of antimicrobial mouthrinses in clinical practice. J Dent Hygiene. 2007 (special suppl);13:13-25.
  22. Meiller TF, Kelley JI, et al. In vitro studies of the efficacy of antimicrobials against fungi. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:663-670.
  23. Fischman SL, Aquirre A, Charles CH. Use of essential oil-containing mouthrinses by xerostomic individuals: determination of potential for oral mucosal irritation. Am J Dent. 2004;17:23-26.
  24. Kerr AR, Katz RW, Ship JA. A comparison of the effects of 2 commercially available nonprescription mouthrinses on salivary flow rates and xerostomia. Quintessence Int. 2007;38(705):41-48.
  25. Kerr AF, Kalliontzi PM, Corby PM, Thai K, Charles C, McGuire J. Comparsion of two mouthrinses on salivary flow and perceived dryness. Abstract. Presented at: IADR General Session. San Diego, CA. March 17, 2011. https://iadr.confex.com/iadr/2011sandiego/webprogram/Paper145075.html
  26. Food and Drug Administration. Oral health care drug products for over-the-counter human use; antigingivitis/antiplaque drug products; establishment of a monograph; proposed rules. Part III. Federal Register. 2003;68(103):32232-32287.
  27. Cole P, Rodu B, Mathisen A. Alcohol-containing mouthwash and oropharyngeal cancer: a review of the epidemiology. J Am Dent Assoc. 2003;134:1079-1087.
  28. La Vecchia C. Mouthwash and oral cancer risk: an update. Oral Oncol. 2009;45(3):198-200.
  29. Boyle P, Gandini S, Boffetta P, Negri E, La Vecchia C. Mouthwash use and oral cancer risk: quantitative meta-analysis of epidemiologic studies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;.112(6):}e130.
  30. Marsh PD, Martin MV, Lewis MOA, Williams D. Dental Plaque. Oral Microbiology E-Book, 5th Edition. Churchill Livingstone. 2009. 80-89.
  31. Bakdash B. Current patterns of oral hygiene product use and practice. Peridontal 2000. 1995;8:11-14.
  32. Cancro LP, Fischman SL. The expected effect on oral hygiene of dental plaque control through mechanical removal. Periodontal 2000. 1995;8:60-74.
  33. Brush Teeth. Mouth Healthy Web site. http://www.mouthhealthy.org/en/az-topics/b/brushing-your-teeth. Accessed July 17, 2015.
  34. Bader HI. Floss or die: implications for dental professionals. Dent Today. 1998;17:76-82.
  35. Health Canada, Canadian Health Measures Survey 2007-2009. “Prevalence and severity of coronal caries – dentate adults”.
  36. Health Canada, Canadian Health Measures Survey 2007-2009. “Percent of participants by highest score for gingivitis – dentate adults”.
  37. Health Canada, Canadian Health Measures Survey 2007-2009.  “Prevalence  and severity of dental caries in primary teeth – ages 6-12”.
  38. Kerr WJS, Kelly J, Geddes DAM. The areas of various surfaces in the human mouth from nine years to adulthood. J Dent Res. 1991;70:1528-1530.
  39. Charles CH, Mostler KM, Bartels LL, Mankodi SM. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol. 2004;31(10):878-884.
  40. Lisante TA, Charles C, Qaqish J, Sharma N, Junker L. Efficacy of brush, floss, rinse regiments vs mechanical oral hygiene. Presented at: 86th General Session of the International Association for Dental Research; March 16-19, 2011; San Diego CA.
  41. Overholser CD, Meiller TF, DePaola LG, Minah GE, Niehaus C. Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. J Clin Periodontol. 1990;17:575-579.
  42. Data on file, Johnson & Johnson Consumer Inc.
  43. Lamster IB, Alfano MC, Seiger MC, Gordon JM. The effect of LISTERINE® Antiseptic on reduction of existing plaque and gingivitis. Clin Prev Dent. 1983;5:12-16.
  44. Cortelli SC, Cortelli JR, Shang H, Costa R, Charles CA. Gingival health benefits of essential-oil and cetylpyridinium chloride mouthrinses: A 6-month randomized clinical study. American Journal of Dentistry. 2014;Vol.27, No.3.
  45. Pan P, Barnett ML, Coelho J et al. Determination of the in situ bactericidal activity of an essential oil mouthrinse using a vital stain method. Clin Periodontal 2000;27(4):256-261
  46. Charles CA, Vair LH, Queiroz D, et al. Comparing consumer acceptance and perceived benefits of two floss technologies. J Dent Hyg. 2009;83(4):222.